Preliminary safety, efficacy and molecular characterization of emavusertib (CA-4948) in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) with FLT3 mutation (FLT3m).

emavusertib (CA-4948) - Curis, Dr. Reddy’s

https://meetings.asco.org/abstracts-presentations/232639/

Eric S. Winer; Amit Verma; Stefanie Groepper; Katharina S. Gotze; Yasmin Abaza; Jan-Henrik Mikesch; Gaurav S Choudhary; Alyssa Masciarelli; Wanying Zhao; Cole Gallagher; Reinhard W. Von Roemeling; Daniel J. DeAngelo

Apr 25, 2024